Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structure of the SH3 domain of human osteoclast-stimulating factor at atomic resolution

Journal Article · · Acta Crystallographica. Section F
;  [1]; ; ;  [1];  [1];  [1];  [1]
  1. Laboratory for Structural Biology, University of Alabama in Huntsville, Huntsville, Alabama 35899 (United States)

The crystal structure of the SH3 domain of human osteoclast-stimulating factor has been determined and refined to the ultrahigh resolution of 1.07 Å. The structure at atomic resolution provides an accurate framework for structure-based design of its inhibitors. Osteoclast-stimulating factor (OSF) is an intracellular signaling protein, produced by osteoclasts themselves, that enhances osteoclast formation and bone resorption. It is thought to act via an Src-related signaling pathway and contains SH3 and ankyrin-repeat domains which are involved in protein–protein interactions. As part of a structure-based anti-bone-loss drug-design program, the atomic resolution X-ray structure of the recombinant human OSF SH3 domain (hOSF-SH3) has been determined. The domain, residues 12–72, yielded crystals that diffracted to the ultrahigh resolution of 1.07 Å. The overall structure shows a characteristic SH3 fold consisting of two perpendicular β-sheets that form a β-barrel. Structure-based sequence alignment reveals that the putative proline-rich peptide-binding site of hOSF-SH3 consists of (i) residues that are highly conserved in the SH3-domain family, including residues Tyr21, Phe23, Trp49, Pro62, Asn64 and Tyr65, and (ii) residues that are less conserved and/or even specific to hOSF, including Thr22, Arg26, Thr27, Glu30, Asp46, Thr47, Asn48 and Leu60, which might be key to designing specific inhibitors for hOSF to fight osteoporosis and related bone-loss diseases. There are a total of 13 well defined water molecules forming hydrogen bonds with the above residues in and around the peptide-binding pocket. Some of those water molecules might be important for drug-design approaches. The hOSF-SH3 structure at atomic resolution provides an accurate framework for structure-based design of its inhibitors.

OSTI ID:
22360165
Journal Information:
Acta Crystallographica. Section F, Journal Name: Acta Crystallographica. Section F Journal Issue: Pt 9 Vol. 62; ISSN ACSFCL; ISSN 1744-3091
Country of Publication:
United Kingdom
Language:
English

Similar Records

Structure of an unconventional SH3 domain from the postsynaptic density protein Shank3 at ultrahigh resolution
Journal Article · Sat Aug 26 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22719049

Crystal Structure of the SH3 Domain of beta PIX in Complex with a High Affinity Peptide from PAK2
Journal Article · Sat Dec 31 23:00:00 EST 2005 · J. Mol. Biol. · OSTI ID:914080

High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site
Journal Article · Mon May 20 00:00:00 EDT 2019 · BMC Molecular and Cell Biology · OSTI ID:1545850